Myriad myPlan™ Lung Cancer measures
expression levels of critical cell cycle genes. Combined with pathologic
tumor stage, the result is correlated with the 5-year risk of lung cancer
death—guiding physicians in making
chemotherapy decisions for early-stage patients.
Myriad myPath™ Melanoma is a unique molecular test created specifically for difficult-to-diagnose melanoma cases. By analyzing 23 genes, the test provides valuable additive molecular information unavailable from any other method for a more informed diagnosis.
Prolaris® measures the expression level of genes involved with tumor proliferation, providing physicians with unique additional information about a patient’s prostate cancer prognosis and may be used with other clinical factors - providing valuable insight into treatment planning.
Myriad ResultsNow™ electronically delivers Myriad test results. Easily view your patient’s test results from anywhere there is an internet connection. View from your office, home, on any hand-held device.
Myriad Genetic Laboratories HIPAA Compliance and Privacy Policies
The Health Insurance Portability and Accountability Act (HIPAA) enacted in 1996 created federal privacy protections that apply to all health information created or maintained by healthcare providers, health plans and healthcare clearinghouses. State laws have also been enacted to protect patient privacy. In addition to the privacy protections enacted by HIPAA, the law also created federal security standards that apply to protected health information in an electronic format. As a healthcare provider, Myriad Genetic Laboratories, Inc. is considered a HIPAA Covered Entity and is subject to the regulations set forth by the law.
Myriad is dedicated to offering high-quality laboratory services and is committed to securing your privacy through full compliance with HIPAA and an active privacy program. Myriad discloses test results only to the requesting healthcare provider/designee, and not to anyone else (including insurance carriers) without your written permission. Additionally, Myriad does not disclose results to patients directly, but only to their designated healthcare provider.
As mandated by HIPAA, Myriad requires all employees to undergo privacy awareness training and has implemented administrative and technical safeguards to protect patient privacy.
Myriad’s Notice of Privacy Practices describes how your medical information may be used and disclosed (provided to others) and how you can get access to this information.
These forms may be used by patient to exercise their rights as described in Myriad’s Notice of Privacy Practices.
Authorization to Use and Disclose Protected Health Information - This form allows patient to request copies of their medical records, designate a new healthcare provider, and send medical records to individuals, entities, and healthcare providers other than those who ordered their tests.
Request for Amendments/Corrections to Medical Record – Patients may use this form to change or update incorrect or missing information contained in their medical record. Patients do not need to use this form to update address, phone or other contact information, and should contact Myriad’s Customer Service Department at 800-469-7423 to make these changes.
Request for Restrictions – Patients have the right to request certain restrictions on the ways in which Myriad uses and discloses their health information. This form is used to request restrictions.
Request for Confidential Communications - Patients can use this form to request that Myriad contact them using addresses or telephone numbers other than those which we have on file.
Request for Accounting of Disclosures – This form may be used to by patients to request a list of health information disclosures made by Myriad.
If you have questions or complaints about Myriad’s privacy practices please contact our Privacy Office:
Quality and Compliance Department - Privacy Office
320 Wakara Way
Salt Lake City, UT 84108
Further Information about HIPAA please visit: http://www.hhs.gov/ocr/privacy/
BRACAnalysis, COLARIS, COLARIS AP, MELARIS, Myriad myPath, myPlan, myRisk, TheraGuide, PREZEON, PANEXIA, and
Prolaris are either trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and other jurisdictions